Insiders who reported open-market trades in the last 12 months at the companies Benjamin Looker files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Sheldon L. Koenig - $239K in ESPR purchases and sales in the last 12 months
Benjamin Halladay - $51K in ESPR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Benjamin Looker is a corporate insider, tracked as Chief Legal Officer of Esperion Therapeutics, Inc. (ESPR). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Benjamin Looker last file a Form 4?
The most recent primary Form 4 on record is dated 13 July 2026, one of 8 filings going back to 2025.
Has Benjamin Looker been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($80K) across all tracked filings.
Benjamin Looker is Chief Legal Officer of Esperion Therapeutics, Inc. (ESPR). 8 SEC Form 4 filings on record going back to 2025, most recently on 13 July 2026. Most recent open-market trade: sold $37K of ESPR on 18 June 2026. Lifetime open-market sales: $80K.
Recent transactions
8
The latest 8 SEC Form 4 transactions reported by Benjamin Looker.
InsiderAlpha's records for Benjamin Looker go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
